|
|||||
|
|
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients. |
|
| Authors: | K Ohyashiki Y Aota D Akahane A Gotoh K Miyazawa Y Kimura J H Ohyashiki |
| Abstract: | |
| Keywords: | |